SCYNEXIS, Inc. Deferred Revenue
SCYNEXIS, Inc. (SCYX) had Deferred Revenue of $0 as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-10
- 2026-06-30: Deferred Revenue, Current $0.00.
- 2026-03-31: Deferred Revenue, Current $235.00K.
- 2025-12-31: Deferred Revenue, Current $235.00K.
- 2025-09-30: Deferred Revenue, Current $1.76M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $235.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $235.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.76M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $1.77M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.64M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.64M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $1.64M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.19M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $2.44M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | |
| 2019-12-31 | $0.00 10-K · filed 2020-03-11 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $54.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $121.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $185.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $249.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $257.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $257.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $257.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $257.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $257.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $257.00K 10-K · filed 2018-03-13 | |
| 2016-09-30 | $257.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $257.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $257.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $257.00K 10-K · filed 2017-03-13 | |
| 2015-09-30 | $257.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $232.00K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $257.00K 8-K · filed 2015-10-30 | $480.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $257.00K 10-K · filed 2016-03-07 | $449.00K 10-K · filed 2015-03-30 |
| 2014-09-30 | $536.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $621.00K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $1.25M 10-Q/A · filed 2014-07-11 | |
| 2013-12-31 | $262.00K 8-K · filed 2015-10-30 | $487.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |